Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
NCT ID:
NCT02849912
Eligibility Criteria:
Inclusion Criteria:
* Initial diagnosis of histologically confirmed CD20+ diffuse large B-cell Lymphoma, De novo transformed follicular lymphoma (FL) is allowed
* Follicular lymphoma
* Mantle cell lymphoma
* Previously untreated with chemo- or radiotherapy
* Include in LYSA trial
* Age 18-90 years
Exclusion Criteria:
* Any other type of lymphoma.
* Previous treatment with chemotherapy or radiation therapy
* Contraindication to any drug contained in the chemotherapy regimen
* Previously known HIV positive serology
* Active hepatitis B or C
* Prior history of malignancies other than lymphoma within 3 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT02849912
Study Brief:
Protocol Section:
NCT02849912